CAS RN 252917-06-9
IUPAC Nome:
6-[(2-{[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
Sinonimi:
6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-3H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile
Peso molecolare (g/mol):
465.34
Formula molecolare:
C22H18Cl2N8
InChi Key:
AQGNHMOJWBZFQQ-UHFFFAOYSA-N
SMILES:
CC1=CN=C(N1)C1=CN=C(NCCNC2=NC=C(C=C2)C#N)N=C1C1=C(Cl)C=C(Cl)C=C1
1
–
4
di
4
risultati
1
3
R&D Systems™ CHIR 99021
A Tocris product, part of R&D Systems. CHIR 99021 synthesized to cGMP guidelines
4
Laduviglusib, MedChemExpress
MedChemExpress Laduviglusib (CHIR-99021) is a potent and selective GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal. Laduviglusib induces autophagy.
